ELK4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.602760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.816600E-01
Normal-vs-Stage2
1.951440E-01
Normal-vs-Stage3
1.785160E-01
Normal-vs-Stage4
8.675000E-01
Stage1-vs-Stage2
9.643800E-01
Stage1-vs-Stage3
1.991630E-01
Stage1-vs-Stage4
1.035770E-01
Stage2-vs-Stage3
1.996950E-01
Stage2-vs-Stage4
6.640400E-02
Stage3-vs-Stage4
6.420200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.314230E-01
Normal-vs-AfricanAmerican
9.415200E-01
Normal-vs-Asian
2.135800E-01
Caucasian-vs-AfricanAmerican
5.853600E-02
Caucasian-vs-Asian
9.880000E-01
AfricanAmerican-vs-Asian
1.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.712640E-01
Normal-vs-Female
1.683790E-01
Male-vs-Female
9.774400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.858000E-01
Normal-vs-Age(41-60Yrs)
4.051600E-01
Normal-vs-Age(61-80Yrs)
1.109780E-01
Normal-vs-Age(81-100Yrs)
3.034800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.800600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.386800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.983200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.145800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.875100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.033800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.692400E-01
Normal-vs-Daily Drinker
4.250200E-02
Normal-vs-Weekly Drinker
4.221200E-01
Normal-vs-Occasional Drinker
2.548600E-01
Normal-vs-Social Drinker
4.849600E-01
Non Drinker-vs-Daily Drinker
4.347200E-01
Non Drinker-vs-Weekly Drinker
4.475600E-01
Non Drinker-vs-Occasional Drinker
2.343200E-01
Non Drinker-vs-Social Drinker
1.615020E-01
Daily Drinker-vs-Weekly Drinker
2.608800E-01
Daily Drinker-vs-Occasional Drinker
1.096040E-01
Daily Drinker-vs-Social Drinker
5.590200E-02
Weekly Drinker-vs-Occasional Drinker
9.730800E-01
Weekly Drinker-vs-Social Drinker
7.097800E-01
Occasional Drinker-vs-Social Drinker
6.056600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.492780E-01
Normal-vs-Grade 2
3.019900E-02
Normal-vs-Grade 3
2.392300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.831600E-02
Grade 1-vs-Grade 3
4.798000E-02
Grade 1-vs-Grade 4
1.492780E-01
Grade 2-vs-Grade 3
4.889400E-01
Grade 2-vs-Grade 4
3.019900E-02
Grade 3-vs-Grade 4
2.392300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.450030E-01
Normal-vs-NonDiabetic
1.124440E-01
Diabetic-vs-NonDiabetic
8.272600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.891200E-01
Normal-vs-NoPancreatitis
1.430800E-01
Pancreatitis-vs-NoPancreatitis
6.810600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.539220E-01
Normal-vs-N1
1.901820E-01
N0-vs-N1
7.769400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.048000E-01
Normal-vs-TP53-NonMutant
4.292600E-01
TP53-Mutant-vs-TP53-NonMutant
8.649400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
